Skip to content

Delcath Systems

US · DCTH #3706 by market cap
18.79 -0.45 -2.34%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 13 in the most recent period (2026/Q3).
  • Total institutional ownership rose 16.2 percentage points.

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
68.29% +16.22pp
Institutions
164 +13
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund34.35%
Hedge Fund29.17%
Individual/Insider7.15%
Public Company3.91%
Government Pension Fund0.33%
Private Company0.22%
Insurance Company0.19%
VC/PE Fund0.12%
Other24.56%

Top holders as of 2026-10-13

Rosalind Advisors, Inc. 19.23% · 6.69M sh
BlackRock 11.49% · 4.00M sh
Daniel Kaufman 5.08% · 1.77M sh
Vanguard Capital Management, LLC 3.53% · 1.23M sh
Propel Bio Management, LLC 2.51% · 871.46K sh
Geode Capital Management, LLC 2.37% · 822.90K sh
State Street Global Advisors 2.18% · 759.94K sh
Algert Global LLC 1.67% · 580.71K sh
Millennium Management LLC 1.63% · 566.37K sh
Divisadero Street Capital Management, LP 1.44% · 499.80K sh
Morgan Stanley Investment Management Inc. 1.58% · 550.56K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 45 buys · 5 sells

NameRoleStake
Rosalind Advisors, Inc. -- 19.23%
Gerard Michel Chief Executive Officer 0.98%
Vojislav Vukovic Chief Medical Officer 0.49%
David Hoffman General Counsel, Corporate Secretary & Chief Compliance Officer 0.25%
Sandra Pennell Chief Financial Officer 0.22%
Kevin Muir Chief Commercial Officer 0.07%
Gilad Aharon Independent Director 0.15%
John Sylvester Independent Chairperson 0.04%
Martha Rook Chief Operating Officer 0.02%
Elizabeth Czerepak Independent Director --
Steven Salamon Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-11 Bridget Martell Director Derivative Exercise and Sale -22,500 $7.85–22.26
2026-10-12 Rosalind Advisors, Inc. -- Other Disposition -23,875 --
2026-10-12 Rosalind Advisors, Inc. -- Derivative Exercise and Sale -3,627 --
2026-05-12 Elizabeth Czerepak Independent Director Other Derivative Acquisition +22,500 $11.61
2026-05-12 Steven Salamon Independent Director Other Derivative Acquisition +22,500 $11.61
2026-05-12 John Sylvester Independent Chairperson Other Derivative Acquisition +22,500 $11.61
2026-05-12 Gilad Aharon Independent Director Other Derivative Acquisition +22,500 $11.61
2026-05-12 Bridget Martell Director Other Derivative Acquisition +22,500 $11.61
2026-03-05 Sandra Pennell Chief Financial Officer Open Market Acquisition +5,533 $9.04
2026-03-01 Gerard Michel Chief Executive Officer Open Market Acquisition +11,200 $8.96
2026-02-16 Gerard Michel Chief Executive Officer Other Derivative Acquisition +97,500 --
2026-02-16 Gerard Michel Chief Executive Officer Other Derivative Acquisition +195,000 $9.40
2026-02-16 Vojislav Vukovic Chief Medical Officer Other Derivative Acquisition +28,250 --
2026-02-16 Vojislav Vukovic Chief Medical Officer Other Derivative Acquisition +56,500 $9.40
2026-02-16 Sandra Pennell Chief Financial Officer Other Derivative Acquisition +28,250 --
2026-02-16 Sandra Pennell Chief Financial Officer Other Derivative Acquisition +56,500 $9.40
2026-02-16 Martha Rook Chief Operating Officer Other Derivative Acquisition +28,250 --
2026-02-16 Martha Rook Chief Operating Officer Other Derivative Acquisition +56,500 $9.40
2026-02-16 David Hoffman General Counsel, Corporate Secretary & Chief Compliance Officer Other Derivative Acquisition +28,250 --
2026-02-16 David Hoffman General Counsel, Corporate Secretary & Chief Compliance Officer Other Derivative Acquisition +56,500 $9.40

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Delcath Systems discussion 0 comments

Add a comment